KalVista Pharmaceuticals, Inc. (KALV) had achieved a huge win announced just the other day on July 7th of 2025, whereby the FDA had approved its oral on-demand Hereditary Angioedema [HAE] plasma ...
Hereditary angioedema (HAE) is a rare genetic disorder that causes episodes of severe swelling throughout your body. It is caused by abnormal immune responses. But unlike allergic swelling, HAE is not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results